Microfluidics

Organ-on-Chip Engineering

Organ-on-chip engineering represents a major breakthrough in modeling human physiology by recreating organ-specific microenvironments within microfluidic systems. These platforms simulate tissue–tissue interfaces, biomechanical cues, and fluid transport, allowing realistic assessment of drug responses, toxicity profiles, and disease mechanisms. Continuous improvements in biomaterials, microchannel architectures, and dynamic flow control help mimic the structural and functional properties of organs such as the lung, liver, heart, and intestine. Integration with stem cell–derived organoids and patient-specific cells enhances predictive accuracy, supporting the development of personalized therapies and reducing dependence on animal models. Multi-organ chip systems further advance understanding of systemic interactions, pharmacokinetics, and multi-tissue communication. Data generated from these platforms accelerate drug discovery, safety assessment, and mechanistic research in ways previously unattainable through conventional methods. As organ-on-chip devices gain regulatory recognition and commercial viability, they are emerging as essential tools for biomedical research and translational science.